Cancer Pathology Data Sharing
2.0.0-ballot - STU 2 Ballot
Cancer Pathology Data Sharing
2.0.0-ballot - STU 2 Ballot
This page is part of the Sharing eCC Data from Pathology Labs to EHR (v2.0.0-ballot: STU 2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This version is a pre-release. The current official version is 1.0.1. For a full list of available versions, see the Directory of published versions
| Page standards status: Trial-use |
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:CodeSystem ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "cap-ecc-codesystem"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cap-ecc-codesystem</b></p><a name=\"cap-ecc-codesystem\"> </a><a name=\"hccap-ecc-codesystem\"> </a><a name=\"cap-ecc-codesystem-en-US\"> </a><p>This case-insensitive code system <code>http://hl7.org/fhir/us/cancer-reporting/CodeSystem/cap-ecc-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">31357.100004300<a name=\"cap-ecc-codesystem-31357.46100004300\"> </a></td><td>Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))</td></tr><tr><td style=\"white-space:nowrap\">30148.100004300<a name=\"cap-ecc-codesystem-30148.46100004300\"> </a></td><td>Tumor Size (Note E)</td></tr><tr><td style=\"white-space:nowrap\">51180.100004300<a name=\"cap-ecc-codesystem-51180.46100004300\"> </a></td><td>Tumor Site (Note B)</td></tr><tr><td style=\"white-space:nowrap\">16448.100004300<a name=\"cap-ecc-codesystem-16448.46100004300\"> </a></td><td>Single focus of invasive carcinoma</td></tr><tr><td style=\"white-space:nowrap\">38392.100004300<a name=\"cap-ecc-codesystem-38392.46100004300\"> </a></td><td>Tumor Focality (Note F)</td></tr><tr><td style=\"white-space:nowrap\">16214.100004300<a name=\"cap-ecc-codesystem-16214.46100004300\"> </a></td><td>Specimen Laterality</td></tr><tr><td style=\"white-space:nowrap\">16215.100004300<a name=\"cap-ecc-codesystem-16215.46100004300\"> </a></td><td>Right</td></tr><tr><td style=\"white-space:nowrap\">52399.100004300<a name=\"cap-ecc-codesystem-52399.46100004300\"> </a></td><td>HER2 (by immunohistochemistry)</td></tr><tr><td style=\"white-space:nowrap\">36944.100004300<a name=\"cap-ecc-codesystem-36944.46100004300\"> </a></td><td>HER2 (by immunohistochemistry)</td></tr><tr><td style=\"white-space:nowrap\">43789.100004300<a name=\"cap-ecc-codesystem-43789.46100004300\"> </a></td><td>Breast Biomarker Testing Performed on Previous Biopsy</td></tr><tr><td style=\"white-space:nowrap\">41776.100004300<a name=\"cap-ecc-codesystem-41776.46100004300\"> </a></td><td>Estrogen Receptor (ER)</td></tr><tr><td style=\"white-space:nowrap\">45138.100004300<a name=\"cap-ecc-codesystem-45138.46100004300\"> </a></td><td>Estrogen Receptor (ER) Status</td></tr><tr><td style=\"white-space:nowrap\">53472.100004300<a name=\"cap-ecc-codesystem-53472.46100004300\"> </a></td><td>Cannot be determined (indeterminate)</td></tr><tr><td style=\"white-space:nowrap\">16280.100004300<a name=\"cap-ecc-codesystem-16280.46100004300\"> </a></td><td>Invasive carcinoma of no special type (ductal)</td></tr><tr><td style=\"white-space:nowrap\">41794.100004300<a name=\"cap-ecc-codesystem-41794.46100004300\"> </a></td><td>Histologic Type (Note C)</td></tr><tr><td style=\"white-space:nowrap\">16182.100004300<a name=\"cap-ecc-codesystem-16182.46100004300\"> </a></td><td>SPECIMEN</td></tr><tr><td style=\"white-space:nowrap\">17834.100004300<a name=\"cap-ecc-codesystem-17834.46100004300\"> </a></td><td>SPECIAL STUDIES</td></tr><tr><td style=\"white-space:nowrap\">39858.100004300<a name=\"cap-ecc-codesystem-39858.46100004300\"> </a></td><td>Regional Lymph Nodes</td></tr><tr><td style=\"white-space:nowrap\">16697.100004300<a name=\"cap-ecc-codesystem-16697.46100004300\"> </a></td><td>REGIONAL LYMPH NODES (Note M)</td></tr><tr><td style=\"white-space:nowrap\">16717.100004300<a name=\"cap-ecc-codesystem-16717.46100004300\"> </a></td><td>PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</td></tr><tr><td style=\"white-space:nowrap\">16567.100004300<a name=\"cap-ecc-codesystem-16567.46100004300\"> </a></td><td>MARGINS (Note L)</td></tr><tr><td style=\"white-space:nowrap\">868263.100004300<a name=\"cap-ecc-codesystem-868263.46100004300\"> </a></td><td>Lymph Nodes</td></tr><tr><td style=\"white-space:nowrap\">352333.100004300<a name=\"cap-ecc-codesystem-352333.46100004300\"> </a></td><td>DISTANT METASTASIS</td></tr><tr><td style=\"white-space:nowrap\">381061.100004300<a name=\"cap-ecc-codesystem-381061.46100004300\"> </a></td><td>COMMENTS</td></tr><tr><td style=\"white-space:nowrap\">16782.100004300<a name=\"cap-ecc-codesystem-16782.46100004300\"> </a></td><td>ADDITIONAL FINDINGS (Note N)</td></tr><tr><td style=\"white-space:nowrap\">351607.100004300<a name=\"cap-ecc-codesystem-351607.46100004300\"> </a></td><td>?Number of Sentinel Nodes Examined (if applicable)</td></tr><tr><td style=\"white-space:nowrap\">351606.100004300<a name=\"cap-ecc-codesystem-351606.46100004300\"> </a></td><td>Exact number (specify)</td></tr><tr><td style=\"white-space:nowrap\">351601.100004300<a name=\"cap-ecc-codesystem-351601.46100004300\"> </a></td><td>Exact number (specify)</td></tr><tr><td style=\"white-space:nowrap\">351602.100004300<a name=\"cap-ecc-codesystem-351602.46100004300\"> </a></td><td>Total Number of Lymph Nodes Examined (sentinel and non-sentinel)</td></tr><tr><td style=\"white-space:nowrap\">374353.100004300<a name=\"cap-ecc-codesystem-374353.46100004300\"> </a></td><td>Regional lymph nodes present</td></tr><tr><td style=\"white-space:nowrap\">351589.100004300<a name=\"cap-ecc-codesystem-351589.46100004300\"> </a></td><td>Regional Lymph Node Status</td></tr><tr><td style=\"white-space:nowrap\">16736.100004300<a name=\"cap-ecc-codesystem-16736.46100004300\"> </a></td><td>pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension</td></tr><tr><td style=\"white-space:nowrap\">327740.100004300<a name=\"cap-ecc-codesystem-327740.46100004300\"> </a></td><td>pT Category</td></tr><tr><td style=\"white-space:nowrap\">763178.100004300<a name=\"cap-ecc-codesystem-763178.46100004300\"> </a></td><td>pN Category</td></tr><tr><td style=\"white-space:nowrap\">38649.100004300<a name=\"cap-ecc-codesystem-38649.46100004300\"> </a></td><td>pN0: No regional lymph node metastasis identified or ITCs only#</td></tr><tr><td style=\"white-space:nowrap\">58807.100004300<a name=\"cap-ecc-codesystem-58807.46100004300\"> </a></td><td>Procedure (Note A)</td></tr><tr><td style=\"white-space:nowrap\">40307.100004300<a name=\"cap-ecc-codesystem-40307.46100004300\"> </a></td><td>Excision (less than total mastectomy)</td></tr><tr><td style=\"white-space:nowrap\">38391.100004300<a name=\"cap-ecc-codesystem-38391.46100004300\"> </a></td><td>Overall Grade</td></tr><tr><td style=\"white-space:nowrap\">16390.100004300<a name=\"cap-ecc-codesystem-16390.46100004300\"> </a></td><td>Grade 1 (scores of 3, 4 or 5)</td></tr><tr><td style=\"white-space:nowrap\">380283.100004300<a name=\"cap-ecc-codesystem-380283.46100004300\"> </a></td><td>Nottingham Score</td></tr><tr><td style=\"white-space:nowrap\">38125.100004300<a name=\"cap-ecc-codesystem-38125.46100004300\"> </a></td><td>Nuclear Pleomorphism</td></tr><tr><td style=\"white-space:nowrap\">16355.100004300<a name=\"cap-ecc-codesystem-16355.46100004300\"> </a></td><td>Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)</td></tr><tr><td style=\"white-space:nowrap\">16383.100004300<a name=\"cap-ecc-codesystem-16383.46100004300\"> </a></td><td>Score 1</td></tr><tr><td style=\"white-space:nowrap\">38390.100004300<a name=\"cap-ecc-codesystem-38390.46100004300\"> </a></td><td>Mitotic Rate</td></tr><tr><td style=\"white-space:nowrap\">351503.100004300<a name=\"cap-ecc-codesystem-351503.46100004300\"> </a></td><td>?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)</td></tr><tr><td style=\"white-space:nowrap\">351504.100004300<a name=\"cap-ecc-codesystem-351504.46100004300\"> </a></td><td>All margins negative for invasive carcinoma</td></tr><tr><td style=\"white-space:nowrap\">351501.100004300<a name=\"cap-ecc-codesystem-351501.46100004300\"> </a></td><td>Lateral</td></tr><tr><td style=\"white-space:nowrap\">16348.100004300<a name=\"cap-ecc-codesystem-16348.46100004300\"> </a></td><td>Score 2 (10 to 75% of tumor area forming glandular / tubular structures)</td></tr><tr><td style=\"white-space:nowrap\">38124.100004300<a name=\"cap-ecc-codesystem-38124.46100004300\"> </a></td><td>Glandular (Acinar) / Tubular Differentiation</td></tr><tr><td style=\"white-space:nowrap\">44040.100004300<a name=\"cap-ecc-codesystem-44040.46100004300\"> </a></td><td>Ductal Carcinoma In Situ (DCIS) (Note G)</td></tr><tr><td style=\"white-space:nowrap\">16306.100004300<a name=\"cap-ecc-codesystem-16306.46100004300\"> </a></td><td>Not identified</td></tr><tr><td style=\"white-space:nowrap\">352343.100004300<a name=\"cap-ecc-codesystem-352343.46100004300\"> </a></td><td>?Not applicable</td></tr><tr><td style=\"white-space:nowrap\">42418.100004300<a name=\"cap-ecc-codesystem-42418.46100004300\"> </a></td><td>Clock position</td></tr><tr><td style=\"white-space:nowrap\">352334.100004300<a name=\"cap-ecc-codesystem-352334.46100004300\"> </a></td><td>?Distant Site(s) Involved, if applicable</td></tr><tr><td style=\"white-space:nowrap\">16259.100004300<a name=\"cap-ecc-codesystem-16259.46100004300\"> </a></td><td>Specify Clock Position</td></tr><tr><td style=\"white-space:nowrap\">6643.100004300<a name=\"cap-ecc-codesystem-6643.46100004300\"> </a></td><td>8 o'clock</td></tr><tr><td style=\"white-space:nowrap\">16783.100004300<a name=\"cap-ecc-codesystem-16783.46100004300\"> </a></td><td>Additional Findings (specify)</td></tr><tr><td style=\"white-space:nowrap\">31359.100004300<a name=\"cap-ecc-codesystem-31359.46100004300\"> </a></td><td>Additional Dimension in Millimeters (mm)</td></tr><tr><td style=\"white-space:nowrap\">Breast.Invasive.Res.189_4.009.021.REL_sdcFDF<a name=\"cap-ecc-codesystem-Breast.46Invasive.46Res.46189_4.46009.46021.46REL_sdcFDF\"> </a></td><td>INVASIVE CARCINOMA OF THE BREAST: Resection</td></tr><tr><td style=\"white-space:nowrap\">16249.100004300<a name=\"cap-ecc-codesystem-16249.46100004300\"> </a></td><td>TUMOR</td></tr><tr><td style=\"white-space:nowrap\">16403.100004300<a name=\"cap-ecc-codesystem-16403.46100004300\"> </a></td><td>Tumor Extent (Note H)</td></tr><tr><td style=\"white-space:nowrap\">868258.100004300<a name=\"cap-ecc-codesystem-868258.46100004300\"> </a></td><td>Primary Tumor Bed</td></tr><tr><td style=\"white-space:nowrap\">868272.100004300<a name=\"cap-ecc-codesystem-868272.46100004300\"> </a></td><td>RCB Calculations</td></tr></table></div>"^^rdf:XMLLiteral ] ; # fhir:extension ( [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ; fhir:value [ a fhir:code ; fhir:v "oo" ] ] [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"^^xsd:anyURI ] ; fhir:value [ a fhir:code ; fhir:v "trial-use" ; ( fhir:extension [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom"^^xsd:anyURI ] ; fhir:value [ a fhir:canonical ; fhir:v "http://hl7.org/fhir/us/cancer-reporting/ImplementationGuide/hl7.fhir.us.cancer-reporting"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/us/cancer-reporting/ImplementationGuide/hl7.fhir.us.cancer-reporting> ] ] ) ] ] ) ; # fhir:url [ fhir:v "http://hl7.org/fhir/us/cancer-reporting/CodeSystem/cap-ecc-codesystem"^^xsd:anyURI] ; # fhir:version [ fhir:v "2.0.0-ballot"] ; # fhir:name [ fhir:v "CAPeCCCodeSystem"] ; # fhir:title [ fhir:v "CAP eCC CodeSystem"] ; # fhir:status [ fhir:v "active"] ; # fhir:experimental [ fhir:v false] ; # fhir:date [ fhir:v "2025-03-31T19:51:27+00:00"^^xsd:dateTime] ; # fhir:publisher [ fhir:v "HL7 International / Orders and Observations and College of American Pathologists"] ; # fhir:contact ( [ fhir:name [ fhir:v "HL7 International / Orders and Observations and College of American Pathologists" ] ; ( fhir:telecom [ fhir:system [ fhir:v "url" ] ; fhir:value [ fhir:v "http://www.hl7.org/Special/committees/orders" ] ] [ fhir:system [ fhir:v "email" ] ; fhir:value [ fhir:v "ord@lists.HL7.org" ] ] ) ] ) ; # fhir:description [ fhir:v "A CodeSystem for CAP eCC codes"] ; # fhir:jurisdiction ( [ ( fhir:coding [ fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ; fhir:code [ fhir:v "US" ] ] ) ] ) ; # fhir:caseSensitive [ fhir:v false] ; # fhir:content [ fhir:v "complete"] ; # fhir:count [ fhir:v "63"^^xsd:nonNegativeInteger] ; # fhir:concept ( [ fhir:code [ fhir:v "31357.100004300" ] ; fhir:display [ fhir:v "Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))" ] ] [ fhir:code [ fhir:v "30148.100004300" ] ; fhir:display [ fhir:v "Tumor Size (Note E)" ] ] [ fhir:code [ fhir:v "51180.100004300" ] ; fhir:display [ fhir:v "Tumor Site (Note B)" ] ] [ fhir:code [ fhir:v "16448.100004300" ] ; fhir:display [ fhir:v "Single focus of invasive carcinoma" ] ] [ fhir:code [ fhir:v "38392.100004300" ] ; fhir:display [ fhir:v "Tumor Focality (Note F)" ] ] [ fhir:code [ fhir:v "16214.100004300" ] ; fhir:display [ fhir:v "Specimen Laterality" ] ] [ fhir:code [ fhir:v "16215.100004300" ] ; fhir:display [ fhir:v "Right" ] ] [ fhir:code [ fhir:v "52399.100004300" ] ; fhir:display [ fhir:v "HER2 (by immunohistochemistry)" ] ] [ fhir:code [ fhir:v "36944.100004300" ] ; fhir:display [ fhir:v "HER2 (by immunohistochemistry)" ] ] [ fhir:code [ fhir:v "43789.100004300" ] ; fhir:display [ fhir:v "Breast Biomarker Testing Performed on Previous Biopsy" ] ] [ fhir:code [ fhir:v "41776.100004300" ] ; fhir:display [ fhir:v "Estrogen Receptor (ER)" ] ] [ fhir:code [ fhir:v "45138.100004300" ] ; fhir:display [ fhir:v "Estrogen Receptor (ER) Status" ] ] [ fhir:code [ fhir:v "53472.100004300" ] ; fhir:display [ fhir:v "Cannot be determined (indeterminate)" ] ] [ fhir:code [ fhir:v "16280.100004300" ] ; fhir:display [ fhir:v "Invasive carcinoma of no special type (ductal)" ] ] [ fhir:code [ fhir:v "41794.100004300" ] ; fhir:display [ fhir:v "Histologic Type (Note C)" ] ] [ fhir:code [ fhir:v "16182.100004300" ] ; fhir:display [ fhir:v "SPECIMEN" ] ] [ fhir:code [ fhir:v "17834.100004300" ] ; fhir:display [ fhir:v "SPECIAL STUDIES" ] ] [ fhir:code [ fhir:v "39858.100004300" ] ; fhir:display [ fhir:v "Regional Lymph Nodes" ] ] [ fhir:code [ fhir:v "16697.100004300" ] ; fhir:display [ fhir:v "REGIONAL LYMPH NODES (Note M)" ] ] [ fhir:code [ fhir:v "16717.100004300" ] ; fhir:display [ fhir:v "PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)" ] ] [ fhir:code [ fhir:v "16567.100004300" ] ; fhir:display [ fhir:v "MARGINS (Note L)" ] ] [ fhir:code [ fhir:v "868263.100004300" ] ; fhir:display [ fhir:v "Lymph Nodes" ] ] [ fhir:code [ fhir:v "352333.100004300" ] ; fhir:display [ fhir:v "DISTANT METASTASIS" ] ] [ fhir:code [ fhir:v "381061.100004300" ] ; fhir:display [ fhir:v "COMMENTS" ] ] [ fhir:code [ fhir:v "16782.100004300" ] ; fhir:display [ fhir:v "ADDITIONAL FINDINGS (Note N)" ] ] [ fhir:code [ fhir:v "351607.100004300" ] ; fhir:display [ fhir:v "?Number of Sentinel Nodes Examined (if applicable)" ] ] [ fhir:code [ fhir:v "351606.100004300" ] ; fhir:display [ fhir:v "Exact number (specify)" ] ] [ fhir:code [ fhir:v "351601.100004300" ] ; fhir:display [ fhir:v "Exact number (specify)" ] ] [ fhir:code [ fhir:v "351602.100004300" ] ; fhir:display [ fhir:v "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)" ] ] [ fhir:code [ fhir:v "374353.100004300" ] ; fhir:display [ fhir:v "Regional lymph nodes present" ] ] [ fhir:code [ fhir:v "351589.100004300" ] ; fhir:display [ fhir:v "Regional Lymph Node Status" ] ] [ fhir:code [ fhir:v "16736.100004300" ] ; fhir:display [ fhir:v "pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension" ] ] [ fhir:code [ fhir:v "327740.100004300" ] ; fhir:display [ fhir:v "pT Category" ] ] [ fhir:code [ fhir:v "763178.100004300" ] ; fhir:display [ fhir:v "pN Category" ] ] [ fhir:code [ fhir:v "38649.100004300" ] ; fhir:display [ fhir:v "pN0: No regional lymph node metastasis identified or ITCs only#" ] ] [ fhir:code [ fhir:v "58807.100004300" ] ; fhir:display [ fhir:v "Procedure (Note A)" ] ] [ fhir:code [ fhir:v "40307.100004300" ] ; fhir:display [ fhir:v "Excision (less than total mastectomy)" ] ] [ fhir:code [ fhir:v "38391.100004300" ] ; fhir:display [ fhir:v "Overall Grade" ] ] [ fhir:code [ fhir:v "16390.100004300" ] ; fhir:display [ fhir:v "Grade 1 (scores of 3, 4 or 5)" ] ] [ fhir:code [ fhir:v "380283.100004300" ] ; fhir:display [ fhir:v "Nottingham Score" ] ] [ fhir:code [ fhir:v "38125.100004300" ] ; fhir:display [ fhir:v "Nuclear Pleomorphism" ] ] [ fhir:code [ fhir:v "16355.100004300" ] ; fhir:display [ fhir:v "Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)" ] ] [ fhir:code [ fhir:v "16383.100004300" ] ; fhir:display [ fhir:v "Score 1" ] ] [ fhir:code [ fhir:v "38390.100004300" ] ; fhir:display [ fhir:v "Mitotic Rate" ] ] [ fhir:code [ fhir:v "351503.100004300" ] ; fhir:display [ fhir:v "?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)" ] ] [ fhir:code [ fhir:v "351504.100004300" ] ; fhir:display [ fhir:v "All margins negative for invasive carcinoma" ] ] [ fhir:code [ fhir:v "351501.100004300" ] ; fhir:display [ fhir:v "Lateral" ] ] [ fhir:code [ fhir:v "16348.100004300" ] ; fhir:display [ fhir:v "Score 2 (10 to 75% of tumor area forming glandular / tubular structures)" ] ] [ fhir:code [ fhir:v "38124.100004300" ] ; fhir:display [ fhir:v "Glandular (Acinar) / Tubular Differentiation" ] ] [ fhir:code [ fhir:v "44040.100004300" ] ; fhir:display [ fhir:v "Ductal Carcinoma In Situ (DCIS) (Note G)" ] ] [ fhir:code [ fhir:v "16306.100004300" ] ; fhir:display [ fhir:v "Not identified" ] ] [ fhir:code [ fhir:v "352343.100004300" ] ; fhir:display [ fhir:v "?Not applicable" ] ] [ fhir:code [ fhir:v "42418.100004300" ] ; fhir:display [ fhir:v "Clock position" ] ] [ fhir:code [ fhir:v "352334.100004300" ] ; fhir:display [ fhir:v "?Distant Site(s) Involved, if applicable" ] ] [ fhir:code [ fhir:v "16259.100004300" ] ; fhir:display [ fhir:v "Specify Clock Position" ] ] [ fhir:code [ fhir:v "6643.100004300" ] ; fhir:display [ fhir:v "8 o'clock" ] ] [ fhir:code [ fhir:v "16783.100004300" ] ; fhir:display [ fhir:v "Additional Findings (specify)" ] ] [ fhir:code [ fhir:v "31359.100004300" ] ; fhir:display [ fhir:v "Additional Dimension in Millimeters (mm)" ] ] [ fhir:code [ fhir:v "Breast.Invasive.Res.189_4.009.021.REL_sdcFDF" ] ; fhir:display [ fhir:v "INVASIVE CARCINOMA OF THE BREAST: Resection" ] ] [ fhir:code [ fhir:v "16249.100004300" ] ; fhir:display [ fhir:v "TUMOR" ] ] [ fhir:code [ fhir:v "16403.100004300" ] ; fhir:display [ fhir:v "Tumor Extent (Note H)" ] ] [ fhir:code [ fhir:v "868258.100004300" ] ; fhir:display [ fhir:v "Primary Tumor Bed" ] ] [ fhir:code [ fhir:v "868272.100004300" ] ; fhir:display [ fhir:v "RCB Calculations" ] ] ) . #
IG © 2025+ HL7 International / Orders and Observations and College of American Pathologists. Package hl7.fhir.us.cancer-reporting#2.0.0-ballot based on FHIR 4.0.1. Generated 2025-03-31
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change